Study Evaluating the Efficacy and Safety of Darolutamide and Stereotactic Dose Escalated Radiotherapy in Patients With Localized Prostate Cancer and High-risk Features of Relapse
Clinical trial NCT06625970 · RECRUITING
Trial details
- NCT number
- NCT06625970
- Sponsor
- UNICANCER
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-10
- Primary completion
- 2033-10-01
- Enrollment
- 700
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.